4.2 Review

Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial

Jeffrey A. How et al.

Summary: Pembrolizumab may offer clinical benefit to some patients with vaginal or vulvar squamous cell carcinoma, but efficacy varies among individuals. Tumors that are PD-L1 positive may be more sensitive to pembrolizumab. However, treatment may lead to adverse reactions of varying severity.

SCIENTIFIC REPORTS (2021)

Review Oncology

The Radiotherapy Role in the Multidisciplinary Management of Locally Advanced Vulvar Cancer: A Multidisciplinary VulCan Team Review

Luca Tagliaferri et al.

Summary: Locally advanced vulvar cancer (LAVC) requires multidisciplinary management, and radiotherapy plays a relevant role in neoadjuvant, adjuvant, or exclusive treatments. Further research is needed to define the best treatment options based on tumor and patient characteristics, while a multidisciplinary assessment is crucial for personalized treatment.

CANCERS (2021)

Article Oncology

Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study

Baukelien van Triest et al.

Summary: This study evaluated the feasibility of chemoradiation as an alternative to extensive surgery in patients with locally advanced vulvar cancer and reported on locoregional control, toxicity, and survival. The results showed that the treatment regimen was feasible and resulted in effective locoregional control with acceptable survival rates and manageable toxicity.

GYNECOLOGIC ONCOLOGY (2021)

Review Oncology

Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?

Marco Mazzotta et al.

Summary: Vulvar cancer is a challenging clinical condition to treat, with treatment typically involving a combination of surgery, radiotherapy, and chemotherapy tailored to individual patients based on clinical and pathological features. The low incidence of the disease limits the feasibility of randomized trials, resulting in decision-making that relies heavily on evidence from observational studies and clinical practice. Therapeutic management is increasingly personalized at the individual patient level, with a trend towards consolidation of evidence sharing and discussion within a multidisciplinary framework.

CANCERS (2021)

Article Oncology

Use of electrochemotherapy in women with vulvar cancer to improve quality-of-life in the palliative setting: a meta-analysis

Anastasios Tranoulis et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Review Obstetrics & Gynecology

Pembrolizumab in Recurrent Squamous Cell Carcinoma of the Vulva: Case Report and Review of the Literature

LisaB. E. Shields et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2019)

Article Oncology

Neoadjuvant chemotherapy in patients with advanced endometrial cancer

Olivia R. Khouri et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)

Article Obstetrics & Gynecology

Brief Report on 3-Weekly Paclitaxel Carboplatin Efficacy in Locally Advanced or Metastatic Squamous Vulvar Cancer

Frederic Amant et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2018)

Article Oncology

Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer

Divya Natesan et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)

Review Oncology

Risk factors and treatment for recurrent vulvar squamous cell carcinoma

L. S. Nooij et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)

Article Oncology

Treatment of Inoperable Vulvar Cancer Where We Come From and Where Are We Going

Pedro Martinez-Castro et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)

Review Oncology

Systemic treatment of vulvar cancer

Sven Mahner et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2015)

Article Obstetrics & Gynecology

Cancer of the vulva

Neville F. Hacker et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)

Review Cell Biology

Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma

Marta del Pino et al.

HISTOPATHOLOGY (2013)

Article Oncology

Preoperative Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Vulvar Carcinoma: Analysis of Pattern of Relapse

Sushil Beriwal et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Article Oncology

Unresectable Vulval Cancers: Is Neoadjuvant Chemotherapy the Way Forward?

Kathryn Graham et al.

CURRENT ONCOLOGY REPORTS (2013)

Article Oncology

Weekly Paclitaxel/Carboplatin in the Treatment of Locally Advanced, Recurrent, or Metastatic Vulvar Cancer

Sileny N. Han et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)

Article Oncology

Neoadjuvant Chemotherapy in Advanced Vulvar Cancer

Ana Patricia Domingues et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)

Review Oncology

Surgery and radiotherapy in vulvar cancer

J. A. de Hullu et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)

Article Obstetrics & Gynecology

Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways

IAM van der Avoort et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)

Article Oncology

Preoperative chemoradiation for locally advanced carcinoma of the vulva

K Gerszten et al.

GYNECOLOGIC ONCOLOGY (2005)